Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments - Université de Lorraine Access content directly
Journal Articles European Heart Journal Supplements Year : 2019

Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments

Abstract

New therapeutic options to treat hyperkalaemia, such as potassium binders, have been suggested as potentially beneficial by allowing the maintenance (or increase) of the dose of medications that improve outcomes in several cardiovascular conditions, but which have in common the propensity for raising serum potassium. However, potassium binding drugs have yet to prove their causal association with improvements in patients' prognosis before their widespread use can be recommended. In this review we provided an up-to-dare appraisal on potassium binders, their potential clinical applications and directions for future research.
Fichier principal
Vignette du fichier
suy034.pdf (162.28 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-03764606 , version 1 (30-08-2022)

Identifiers

Cite

Faiez Zannad, João Pedro Ferreira, Bertram Pitt. Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments. European Heart Journal Supplements, 2019, 21 (Supplement_A), pp.A55-A60. ⟨10.1093/eurheartj/suy034⟩. ⟨hal-03764606⟩
13 View
12 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More